Open access
107
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer
Yasser Abdel Kader1 Department of Clinical Oncology, Cairo University, Cairo, Egypt
, Marc Spielmann2 Department of Medical Oncology, Institute Gustave Rousssy, VuilleJuif, Paris, France
, Tamer El-Nahas1 Department of Clinical Oncology, Cairo University, Cairo, EgyptCorrespondence[email protected]
, Amr Sakr1 Department of Clinical Oncology, Cairo University, Cairo, Egypt
& Hassan Metwally3 Department of Clinical Oncology, Monufia University, Monufia, Egypt
Pages 37-42
|
Published online: 17 Jun 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.